RC-3095, a Gastrin-Releasing Peptide Receptor Antagonist, Synergizes With Gemcitabine to Inhibit the Growth of Human Pancreatic Cancer CFPAC-1 In Vitro and In Vivo-Reference-Cited by-同舟云学术

RC-3095, a Gastrin-Releasing Peptide Receptor Antagonist, Synergizes With Gemcitabine to Inhibit the Growth of Human Pancreatic Cancer CFPAC-1 In Vitro and In Vivo

Published:2014-01 Issue:1 Volume:43 Page:15-21
ISSN:0885-3177
Container-title:Pancreas
language:en
Short-container-title:

Author:

Hong Shu-Kun,Yang Shi-Yong,Yin Shao-Hua,Yang Kun-Xing

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference45 articles.

1. Global cancer statistics.;Jemal;CA Cancer J Clin,2011

2. Pancreatic cancer: a review of the evidence on causation.;Hart;Clin Gastroenterol Hepatol,2008

3. Effect of gastrin-releasing peptide on the pancreatic tumor cell line (capan).;Avis;Mol Carcinog,1993

4. Gastrin-releasing peptide: in vivo and in vitro growth effects on an acinar pancreatic carcinoma.;Hajri;Cancer Res,1992

5. Bombesin-like peptides: of ligands and receptors.;Spindel;Recent Prog Horm Res,1993

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GRPR antagonist protects from drug-induced liver injury by impairing neutrophil chemotaxis and motility;European Journal of Immunology;2017-04

2. Antitumor effects of herbal mixture extract in the pancreatic adenocarcinoma cell line PANC1;Oncology Reports;2016-09-05

3. G protein-coupled receptors as promising cancer targets;Cancer Letters;2016-07

4. Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment;Expert Opinion on Therapeutic Targets;2016-03-28

5. Bombesin-like peptides and their receptors;Current Opinion in Endocrinology & Diabetes and Obesity;2015-02